Information PortalData PortalKnowledge Portal

Data Matrix

Tools & Workflows

Documentation

1331.49 (Glytoucan)

Id:1b944ac6-224d-5af4-a2f2-3374a8d76f33

Glytoucan:G03921YK

Results found

Linked to

	Label	Description
	1331.49 has glycosequence GLYGEN.GLYCOSEQUENCE:G12518FG-GLYCOSEQ00172797 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1331.49 has glycosequence GLYGEN.GLYCOSEQUENCE:G11655BA-GLYCOSEQ00171314 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1331.49 has glycosequence GLYGEN.GLYCOSEQUENCE:G12518FG-GLYCOSEQ00172795 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1331.49 has motif VIM-2 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1331.49 has glycosequence GLYGEN.GLYCOSEQUENCE:G50384CO-GLYCOSEQ00166928 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1331.49 has glycosequence GLYGEN.GLYCOSEQUENCE:G66512FS-GLYCOSEQ00062958 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1331.49 has glycosequence GLYGEN.GLYCOSEQUENCE:G12518FG-GLYCOSEQ00172799 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1331.49 has glycosequence GLYGEN.GLYCOSEQUENCE:G25844GR-GLYCOSEQ00124754 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1331.49 has glycosequence GLYGEN.GLYCOSEQUENCE:G11655BA-GLYCOSEQ00171317 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1331.49 has glycosequence GLYGEN.GLYCOSEQUENCE:G69360KJ-GLYCOSEQ00115333 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1331.49 has glycosequence GLYGEN.GLYCOSEQUENCE:G12518FG-GLYCOSEQ00172797 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1331.49 has glycosequence GLYGEN.GLYCOSEQUENCE:G11655BA-GLYCOSEQ00171314 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1331.49 has glycosequence GLYGEN.GLYCOSEQUENCE:G12518FG-GLYCOSEQ00172795 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1331.49 has motif VIM-2

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1331.49 has glycosequence GLYGEN.GLYCOSEQUENCE:G50384CO-GLYCOSEQ00166928 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1331.49 has glycosequence GLYGEN.GLYCOSEQUENCE:G66512FS-GLYCOSEQ00062958 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1331.49 has glycosequence GLYGEN.GLYCOSEQUENCE:G12518FG-GLYCOSEQ00172799 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1331.49 has glycosequence GLYGEN.GLYCOSEQUENCE:G25844GR-GLYCOSEQ00124754 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1331.49 has glycosequence GLYGEN.GLYCOSEQUENCE:G11655BA-GLYCOSEQ00171317 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1331.49 has glycosequence GLYGEN.GLYCOSEQUENCE:G69360KJ-GLYCOSEQ00115333 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

DISPLAY PER PAGE

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2025

This repository is under review for potential modification in compliance with Administration directives.